Blue Horseshoe Stocks: New Options Ideas & More

New Options Ideas

The market, which has been struggling mightily here in the opening weeks of 2016 for numerous reasons, appears to be in line for some measure of a rebound today, based on early trading activity. Q4 earnings season has kicked off, which should result in an increase of options trading opportunities in the days and weeks ahead.  In the event this trend holds and progresses, we’re going to want to have a few options contracts ready and waiting in the hopper to watch for swing-trade possibilities.

Shire plc SHPG

SHPG shares are gapping up to the tune of more than 5% in the premarket this morning in the wake of the revelation that Shire would be acquiring US-based Baxalta for a whopping $32B. The deal figures to create the largest rare-disease drugmaker conglomerate in the world.

We like to take advantage of blockbuster reveals such as this, and the trading hysteria they tend to create. For this particular situation, we are going to set our sights on SHPG Weekly $175-180 Calls.

___

Acadia Pharmaceuticals, Inc. ACAD

ACAD has been tumbling down in terms of PPS in recent sessions. The reported possibility of dilution as a result of fundraising via public offering has had investors coming down on the bearish side of the fence. We want to be on the lookout for the possibility of a rebound. If such a move occurs we’re going to have the ACAD 02/19 $29 Calls and 03/18 $30 Calls on our radars moving forward.


Alcoa, Inc. AA – Possible Recovery Play

AA is striking us as a stock whose time for a rebound may be fast approaching. We want to signal this as a potential bottom-play. The strength index is heading into heavily oversold territory, and a triple-bottom setup suggests AA could be nearing basement-level prices.

We’re going to add this to our current list of bottom-watch plays, which also includes KOOL, MGI, GNBT, and MAXD.


Extended Watchlist:
HCTI, IMTV, BLTA, AAPL

Blue Horseshoe Stocks: Multiple Bottom-Watch Plays & More

Extended-Term Bottom Watchlist

The new year has been off to an uncharacteristically sluggish start for stocks due to worries over China’s struggling economy and the global ripple effect it figures to have, as well as a sharp drop in oil prices. An environment such as this doesn’t discourage us as much as change the types of opportunities we’re after. Troublesome times lead to cheap shares and along those lines, we’ve had a handful of stocks jump out at us as potential bottom-plays.

We’re going to have each of the following on our radars in the days and weeks ahead:

Cesca Therapeutics, Inc. KOOL

Max Sound Corp. MAXD

Generex Boitech, Inc. GNBT

MoneyGram International, Inc. MGI

As we stated above, the general sentiment of the market is bearish at the moment, so we will need to allow each of these room to set new lows before they begin to rebound, but in each case, potential gains on eventual recoveries will be significant, so we’ll want to keep a close eye to make sure we’re hanging around when the fun begins.


Trans-Pacific Aerospace Co., Inc. TPAC

We’ve been following TPAC regularly since the second week in December, sending out reminders of our interest in our reports last Thursday and Monday mornings as well. The stock has essentially been in a consistent uptrend the entire time.

This week alone, TPAC has surged 123% from a low of .0031 to yesterday’s high of .0069. The overall swing we’ve witnessed since our initial alert less than a month ago, is a far more impressive jump of 1050% (.0006-.0069). For our feelings on TPAC to remain bullish from this point forward, we’ll need to see the stock maintain support at or above .005 on any pullbacks.


Constellation Brands, Inc. STZ – Options Idea

STZ appears to be bucking the trend in the midst of a languorous market. While many, if not most stocks are gapping down, we want to pay close attention to STZ as it is currently showing strength.

We’ll put a range of options calls on watch for possible swing-trade chances today and in sessions to come, namely STZ 01/15 $135-150 Calls.


Extended Watchlist:
 EMBR, COLV, PFSD, WRFX